Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Mesothelioma, Malignant 5Hepatoblastoma 3Drug-Related Side Effects and Adverse Reactions 3Central Nervous System Neoplasms 3Ototoxicity 2Oligodendroglioma 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Glioma 2Gastrointestinal Neoplasms 2Astrocytoma 2Thrombocytopenia 1Testicular Neoplasms 1Stomach Neoplasms 1Seminoma 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Mouth Neoplasms 1Mesothelioma 1Lymphoma 1Liver Neoplasms 1Liposarcoma 1

Interventions

Cisplatin 21pembrolizumab 16Gemcitabine 16Paclitaxel 15Radiotherapy 14Carboplatin 14Radiotherapy, Intensity-Modulated 13Cyclophosphamide 9Cetuximab 9Magnetic Resonance Spectroscopy 8Radiation 7padeliporfin 6Specimen Handling 6Oxaliplatin 6Fluorouracil 6Drug Therapy 6Docetaxel 6Capecitabine 6Bevacizumab 6anlotinib 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Celecoxib 5poly ICLC 4fludarabine 4Standard of Care 4Sorafenib 4Leucovorin 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma × sodium thiosulfate × Clear all
NCT04541355 2024-06-28

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

University of California, San Francisco

Phase 2 Completed
16 enrolled 12 charts
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡